Dania Felipe-Ramirez
Pediatric Endocrinology · New Orleans, LANPI 1184814659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 119 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$341
- AstraZeneca$270
- AbbVie$194
- Ultragenyx Pharmaceutical Inc.$185
- BETA Bionics, Inc.$180
- Lilly USA, LLC$143
- plus $1K from 24 others
Across 14 payments — averaging $255.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amryt Pharma Holdings Ltd$2K
- Aegerion Pharmaceuticals, Inc.$2K
- Chiesi USA, Inc.$255
What the payments were for
- Food & beverage$2,624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $341 |
| AstraZeneca | 9 | $270 |
| AbbVie | 11 | $194 |
| Ultragenyx Pharmaceutical Inc. | 5 | $185 |
| BETA Bionics, Inc. | 4 | $180 |
| Lilly USA, LLC | 9 | $143 |
| Pfizer | 6 | $142 |
| Ascendis Pharma Endocrinology Inc | 7 | $135 |
| Medtronic(2 entities) | 6 | $123 |
| Endo Pharmaceuticals Inc. | 6 | $107 |
| Tolmar, Inc. | 4 | $90 |
| Arbor Pharmaceuticals, Inc. | 5 | $86 |
| Lifescan, Inc. | 5 | $74 |
| Dexcom, Inc. | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Rhythm Pharmaceuticals, Inc. | 3 | $56 |
| Biomarin Pharmaceutical Inc. | 2 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Ascensia Diabetes Care US Inc. | 1 | $35 |
| Mannkind Corporation | 1 | $33 |
| Insulet Corporation | 2 | $33 |
| Tandem Diabetes Care, Inc. | 1 | $32 |
| Zealand Pharma US, Inc. | 1 | $27 |
| Abbott | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Tolmar Pharmaceuticals, Inc. | 1 | $22 |
| Soleno Therapeutics, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $17 |
| Eton Pharmaceuticals, Inc. | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$413
- CRYSVITA$106
How this compares
Too few pediatric endocrinology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in New Orleans
- Stuart ChalewNew Orleans$7K
- Ricardo GomezNew Orleans$6K
- Cielo AlleynNew Orleans$3K
- Arlette Soros DupreNew Orleans$2K
- Carmen MironoviciNew Orleans$923
- Aqeel AlaqeelNew Orleans$131
- Alfonso Vargas-Del ValleNew Orleans$23
- Janna Flint WilsonLafayette$5K
- Sasi PenukondaShreveport$2K
- Chantal LutfallahBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.